Frazier Life Sciences Management, L.P.
PALO ALTO, CA · CIK 1892134 · 13F filing filed 2022-08-10
SEC-registered investment adviser since 2021 · limited partnership
- Assets managed$7.0bn
- Staff64 · 47 in investment roles
- Main clients (by assets)Private funds 100%
- Private funds8 (1 hedge) · $7.0bn gross assets
- Websitefrazierls.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityFrazier Life Sciences Management, L.P. (US)
- Kindhedge funds, private equity, venture
- Others nearbyPalo Alto, CA, San Diego, CA
As an employer
- Offices in1 country
- Private fundsventure capital 4, hedge 1, private equity 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| Palo Alto, CA (main office)United States | about 44 |
| San Diego, CAUnited States | 3 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
$1.1bn
reported value
-9.7% vs Q1 2022
41positions
68.2%in top 10
2 new
8 added
8 reduced
3 sold out
vs Q1 2022
Holdings, Q2 2022
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC ARQT | $179.7m16.96% | Unchanged |
| HILLEVAX INC COM | $101.5m9.58% | New |
| KRYSTAL BIOTECH INC KRYS | $71.9m6.79% | Added +229.2k |
| MIRUM PHARMACEUTICALS INC MIRM | $69.4m6.55% | Unchanged |
| CHINOOK THERAPEUTICS INC ADRO | $62.9m5.93% | Added +883.0k |
| SYNDAX PHARMACEUTICALS INC SNDX | $61.5m5.80% | Unchanged |
| PHATHOM PHARMACEUTICALS INC PHAT | $49.2m4.64% | Unchanged |
| SIERRA ONCOLOGY INC COM NEW | $47.9m4.52% | Reduced -1.5m |
| IMAGO BIOSCIENCES INC COM | $39.8m3.75% | Unchanged |
| VAXCYTE INC PCVX | $38.9m3.67% | Reduced -522.1k |
| CRINETICS PHARMACEUTICALS IN CRNX | $26.4m2.49% | Unchanged |
| TARSUS PHARMACEUTICALS INC TARS | $26.1m2.46% | Added +370.4k |
| ALPINE IMMUNE SCIENCES INC NVLS | $25.4m2.40% | Reduced -1.2m |
| TRICIDA INC TCDA | $20.2m1.90% | Unchanged |
| COGENT BIOSCIENCES INC COGT | $18.9m1.78% | Reduced -557.6k |
| ANAPTYSBIO INC ANAB | $18.3m1.72% | Unchanged |
| GRACELL BIOTECHNOLOGIES INC SPONSORED ADS | $17.1m1.62% | Reduced -334.4k |
| KALVISTA PHARMACEUTICALS INC KALV | $15.5m1.46% | Unchanged |
| MERUS N V MRUS | $15.3m1.44% | Added +45.0k |
| FRAZIER LIFESCIENCES ACQU CO UNIT 12/09/2025 | $14.8m1.40% | Unchanged |
| REPLIMUNE GROUP INC REPL | $14.1m1.33% | Added +89.5k |
| GRITSTONE BIO INC GRTS | $12.7m1.20% | Unchanged |
| ARVINAS INC ARVN | $12.0m1.13% | Added +15.0k |
| PASSAGE BIO INC COM | $11.8m1.12% | Unchanged |
| VIRIDIAN THERAPEUTICS INC VRDN | $11.3m1.07% | Reduced -759.2k |
| AUTOLUS THERAPEUTICS PLC AUTL | $10.6m1.00% | Unchanged |
| INTELLIA THERAPEUTICS INC NTLA | $10.5m0.99% | Unchanged |
| SILENCE THERAPEUTICS PLC SLN | $10.4m0.99% | Unchanged |
| TYRA BIOSCIENCES INC TYRA | $9.8m0.93% | Added +47.4k |
| SUTRO BIOPHARMA INC COM | $9.3m0.87% | Unchanged |
| ACLARIS THERAPEUTICS INC ACRS | $5.7m0.54% | Unchanged |
| CEREVEL THERAPEUTICS HLDNG I CERE | $5.3m0.50% | Added +146.4k |
| TREVI THERAPEUTICS INC TRVI | $3.3m0.31% | New |
| PARDES BIOSCIENCES INC COM | $2.6m0.24% | Reduced -1.2m |
| IMMUNOVANT INC IMVT | $2.3m0.22% | Unchanged |
| ESSA PHARMA INC EPI | $2.2m0.21% | Unchanged |
| IVERIC BIO INC OPHT | $1.6m0.15% | Reduced -2.3m |
| MOLECULAR TEMPLATES INC COM | $1.3m0.12% | Unchanged |
| EPIZYME INC EPZM | $1.1m0.10% | Unchanged |
| APTINYX INC COM | $1.1m0.10% | Unchanged |
| NABRIVA THERAPEUTICS PLC SHS | $77.0k0.01% | Unchanged |
Sold out since Q1 2022
| Security | Value then |
|---|---|
| BICYCLE THERAPEUTICS PLC BCYC | $26.5m603.5k shares |
| AVADEL PHARMACEUTICALS PLC | $6.5m951.8k shares |
| SCHOLAR ROCK HLDG CORP SRRK | $2.0m156.0k shares |